ফুসফুসৰ কেন্সাৰ (নন-স্মল চেল)
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
ক’ত যাব
এই ট্ৰায়েলৰ বাবে ভাৰতৰ 6 খন চিকিৎসালয়ত ৰোগী লোৱা হৈছে।
ৰেজিষ্ট্ৰীৰ সাৰাংশ (কাৰিকৰী)
The purpose of this study is to understand if PF-08046054 alone works well compared to standard-of-care docetaxel alone in participants with non-small cell lung cancer (NSCLC) with PD-L1 expression greater than or equal to 1% and had cancer progression during or after treatment with PD-L1 or PD-1 inhibitors, platinum-based chemotherapy, and targeted treatment regimen(s) for participants with known actionable genomic alterations (AGAs). Participants in this study must have cancer that has spread through their body or can't be removed with surgery or treated with definitive radiation. Participa…
স্পন্সৰ: Pfizer
ClinicalTrials.gov ত NCT07144280
ৰেজিষ্ট্ৰীত শেষ আপডেট 13 Oct 2026 · আমি 20 Oct 2026 ত পঢ়িছোঁ